These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27670878)

  • 1. Commentary regarding a recent collaborative consensus statement addressing prostate MRI and MRI-targeted biopsy in patients with a prior negative prostate biopsy.
    Verma S; Rosenkrantz AB; Choyke P; Eberhardt SC; Eggener SE; Gaitonde K; Haider MA; Margolis DJ; Marks LS; Pinto P; Sonn GA; Taneja SS
    Abdom Radiol (NY); 2017 Feb; 42(2):346-349. PubMed ID: 27670878
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiparametric magnetic resonance imaging-targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results.
    Abdi H; Zargar H; Goldenberg SL; Walshe T; Pourmalek F; Eddy C; Chang SD; Gleave ME; Harris AC; So AI; Machan L; Black PC
    Urol Oncol; 2015 Apr; 33(4):165.e1-7. PubMed ID: 25665509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted prostate biopsy and MR-guided therapy for prostate cancer.
    Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
    Abdom Radiol (NY); 2016 May; 41(5):877-88. PubMed ID: 26907717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MRI of the prostate].
    Nörenberg D; Solyanik O; Schlenker B; Magistro G; Ertl-Wagner B; Clevert DA; Stief C; Reiser MF; D'Anastasi M
    Urologe A; 2017 May; 56(5):665-677. PubMed ID: 28424829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Not Available].
    Klingebiel M; Ullrich T; Rabenalt R; Albers P; Antoch G; Schimmöller L
    Rofo; 2018 Nov; 190(11):1067-1069. PubMed ID: 29874701
    [No Abstract]   [Full Text] [Related]  

  • 6. MRI of Prostate Cancer: Update.
    Verma S
    Top Magn Reson Imaging; 2016 Jun; 25(3):101. PubMed ID: 27187166
    [No Abstract]   [Full Text] [Related]  

  • 7. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis.
    Martin PR; Cool DW; Romagnoli C; Fenster A; Ward AD
    Med Phys; 2014 Jul; 41(7):073504. PubMed ID: 24989418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of MRI prebiopsy in men at risk for prostate cancer: taking off the blindfold.
    Bjurlin MA; Rosenkrantz AB; Taneja SS
    Curr Opin Urol; 2017 May; 27(3):246-253. PubMed ID: 28234749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.
    Cash H; Günzel K; Maxeiner A; Stephan C; Fischer T; Durmus T; Miller K; Asbach P; Haas M; Kempkensteffen C
    BJU Int; 2016 Jul; 118(1):35-43. PubMed ID: 26384851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
    Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
    Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paradigm shift in urology : Prostate cancer diagnosis using MRI-targeted or standard transrectal ultrasonography-guided biopsy].
    Hadaschik B
    Urologe A; 2018 Jun; 57(6):727-728. PubMed ID: 29740666
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
    Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
    Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time Virtual Sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data.
    Miyagawa T; Ishikawa S; Kimura T; Suetomi T; Tsutsumi M; Irie T; Kondoh M; Mitake T
    Int J Urol; 2010 Oct; 17(10):855-60. PubMed ID: 20807266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy].
    Kesch C; Radtke JP; Distler F; Boxler S; Klein T; Hüttenbrink C; Hees K; Roth W; Roethke M; Schlemmer HP; Hohenfellner M; Hadaschik BA
    Urologe A; 2016 Aug; 55(8):1071-7. PubMed ID: 27168038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR-TRUS Fusion Biopsy.
    Margolis DJ
    Top Magn Reson Imaging; 2016 Jun; 25(3):125-31. PubMed ID: 27187163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer: state of the art imaging and focal treatment.
    Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
    Clin Radiol; 2017 Aug; 72(8):665-679. PubMed ID: 28385253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
    Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM
    Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
    Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
    J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial.
    Wysock JS; Rosenkrantz AB; Huang WC; Stifelman MD; Lepor H; Deng FM; Melamed J; Taneja SS
    Eur Urol; 2014 Aug; 66(2):343-51. PubMed ID: 24262102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Prostate Imaging Reporting and Data System Classification in the Prediction of Tumor Aggressiveness in Targeted Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy.
    Borkowetz A; Platzek I; Toma M; Renner T; Herout R; Baunacke M; Laniado M; Baretton GB; Froehner M; Zastrow S; Wirth MP
    Urol Int; 2017; 99(2):177-185. PubMed ID: 28531902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.